Sharper & Granite’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$628K Hold
4,969
0.19% 77
2026
Q1
$693K Sell
4,969
-359
-7% -$50.3K 0.24% 73
2025
Q4
$654K Sell
5,328
-240
-4% -$29.2K 0.23% 73
2025
Q3
$618K Buy
5,568
+11
+0.2% +$1.25K 0.22% 73
2025
Q2
$620K Hold
5,557
0.24% 76
2025
Q1
$623K Sell
5,557
-374
-6% -$38.6K 0.26% 76
2024
Q4
$548K Hold
5,931
0.24% 78
2024
Q3
$497K Buy
5,931
+818
+16% +$62.4K 0.22% 77
2024
Q2
$351K Sell
5,113
-1,477
-22% -$98.6K 0.17% 84
2024
Q1
$459K Sell
6,590
-796
-11% -$61.2K 0.22% 78
2023
Q4
$598K Buy
+7,386
New +$575K 0.31% 72

Other funds holding GILD

Sharper & Granite's GILD Position: Q2 2026 in Review

Sharper & Granite held its Gilead Sciences (GILD) position steady in Q2 2026 at 4,969 shares worth $628K. The position accounts for 0.19% of the portfolio, ranked #77.

Sharper & Granite first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $693K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sharper & Granite held 4,969 shares of Gilead Sciences worth $628K as of Q2 2026.
  • Sharper & Granite left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.19% of Sharper & Granite's portfolio in Q2 2026, its #77 holding.
  • Sharper & Granite first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Sharper & Granite's Gilead Sciences position peaked at $693K in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sharper & Granite's 13F filing for Q2 2026, filed 16 Jul 2026.